Moderna Inc (NAS:MRNA)
$ 128.32 2.65 (2.11%) Market Cap: 49.18 Bil Enterprise Value: 40.89 Bil PE Ratio: 0 PB Ratio: 3.83 GF Score: 68/100

Moderna Inc Science & Technology Day Transcript

May 17, 2022 / 01:00PM GMT
Release Date Price: $142.28 (+4.42%)
Stephane Bancel
Moderna, Inc. - CEO & Director

Well, good morning, everybody. Good afternoon, if you are live. Thank you so much for joining us. We are so happy to see you in person. So thank you for making the trip, some of you from far away, some of you from New York or other places in the U.S., to be with us today. It is our first live meeting since the pandemic started. The last one was in 2019, in R&D day in New York.

If it's okay with you, I would like to thank and congratulate the Moderna team for the amazing work that has happened. If you think about it, it has been 10 years of really hard work to make the science work, so we could be ready for this moment. And as you can imagine, it has been a crazy 2 years over the last 2 years. So please join me, thank all of the scientists.

So as you know, I'll be making forward-looking statements. There are a lot of risk involved in investing in Moderna. You can look at those in our SEC documents or on our website.

So we believe mRNA is a unique opportunity to change medicine forever. As you all know, we are very excited

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot